1. Vieweg J, Panzer S, Schaefer S. Effects of age simulation and age on motor sequence learning: Interaction of age-related cognitive and motor decline. Human Movement Science. 2023; 1; 87: 103025.
2. Bacanoiu MV, Danoiu M. New strategies to improve the quality of life for normal aging versus pathological aging. Journal of Clinical Medicine. 2022; 20; 11(14): 4207.
3. Poirier G, Ohayon A, Juranville A, Mourey F, Gaveau J. Deterioration, compensation and motor control processes in healthy aging, mild cognitive impairment and Alzheimer’sdisease. Geriatrics. 2021; 6(1): 33.
4. Khaledi S, Ahmadi S. Amyloid Beta and Tau: From Physiology to Pathology in Alzheimer’s Disease.Neurosci J Shefaye Khatam 2016; 4(4): 67-88. [In Persian].
5. Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH. Amyloid beta in aging and Alzheimer’s disease. International journal of molecular sciences. 2022; 26; 23(21): 12924.
6. Mandal PK, Roy RG, Samkaria A. Oxidative Stress: Glutathione and Its Potential to Protect Methionine-35 of Aβ Peptide from Oxidation. Acs Omega. 2022; 26; 7(31): 27052-61.
7. Doros tkar MM, Zou C, Blazquez-Llorca L, Herms J. Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities. Acta Neuropathol. 2015; 130(1): 1-19.
8. Manocha GD, Floden AM, Rausch K, Kulas JA, McGregor BA, Rojanathammanee L, et al. APP regulates microglial phenotype in a mouse model of Alzheimer’s disease. J Neurosci. 2016; 36(32): 8471-86.
9. Zheng F, Luo Y, Wang H. Regulation of BDNF-mediated transcription of immediate early gene Arc by intracellular calcium and calmodulin. Journal of neuroscience research. 2009; 87(2): 380.
10. Bramham CR, Worley PF, Moore MJ, et al. The immediate early gene Arc/Arg3.1: regulation, mechanisms, and function. The Journal of Neuroscience 2008; 1228(46): 11760-7.
11. Wang Z, Tan L, Zong Y, Ma YH, Wang ZB, Wang HF, Tan L. sTREM2 and GFAP Mediated the Association of IGF-1 Signaling Biomarkers with Alzheimer’s Disease Pathology. Journal of Alzheimer's Disease. 2023 (Preprint): 1-7.
12. Gaitán JM, Moon HY, Stremlau M, Dubal DB, Cook DB, Okonkwo OC, Van Praag H. Effects of aerobic exercise training on systemic biomarkers and cognition in late middle-aged adults at risk for Alzheimer’s disease. Frontiers in Endocrinology. 2021; 20; 12: 660181.
13. Yang L, Wang Y, Li Z, Wu X, Mei J, Zheng G. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease. Carbohydrate Polymers. 2023; 310: 120714.
14. Mehrabi A, Gaeini A, Nouri R, Daryanoosh F. The effect of six-week HIIT swimming exercise and Resveratrol supplementation on the level of SIRT3 in frontal lobe of aged rats. The Neuroscience Journal of Shefaye Khatam. 2021; 10; 9(2): 48-59.
15. Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Molecular Neurobiology. 2017; 54(3): 2269-85.
16. Elsallabi O, Patruno A, Pesce M, Cataldi A, Carradori S, Gallorini M. Fisetin as a senotherapeutic agent: biopharmaceutical properties and crosstalk between cell senescence and neuroprotection. Molecules. 2022; 23; 27(3): 738.
17. Mizui T, Ishikawa Y, Kumanogoh H, Lume M, Matsumoto T, Hara T, et al. BDNF pro-peptide actions facilitate hippocampal LTD and are altered by the common BDNF polymorphism Val66Met. Proc Natl Acad Sci USA 2015; 112(23): E3067-74
18. Palop JJ, Chin J, Bien-Ly N, Massaro C, Yeung BZ, Yu GQ, Mucke L. Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice. J Neurosci Res. 2005;19; 25(42): 9686-93
19. Shamsipour S, Sharifi G, Taghian F. Impact of interval training with probiotic (L. plantarum/Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease. Neurosci Lett. 2021; 21; 756: 135949
20. Qarari R, Saqib Jo M, Hedayati M, Fathi, R. The effect of aerobic exercise and omega-3 consumption on brain-derived neurotrophic factor in the hippocampus of male Alzheimer's rats treated with homocysteine. Sci J Kurdistan Uni Med Sci. 2016; 10; 21(2): 53-64
21. Leung HW, Foo G, VanDongen A. Arc regulates transcription of genes for plasticity, excitability and Alzheimer’s disease. Biomedicines. 2022; 11; 10(8): 1946.
22. Kaushik M, Kaushik P, Parvez S. Memory related molecular signatures: The pivots for memory consolidation and Alzheimer's related memory decline. Ageing Res Rev. 2022; 29: 101577.
23. López-Ortiz S, Lista S, Valenzuela PL, Pinto-Fraga J, Carmona R, Caraci F, Caruso G, Toschi N, Emanuele E, Gabelle A, Nisticò R. Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses. J Neurol. 2023; 270(2): 711-25
24. Arnarson A, Gudny Geirsdottir O, Ramel A, Jonsson PV, Thorsdottir I. Insulin-like growth factor-1 and resistance exercise in community dwelling old adults. The Journal of Nutrition, Health and Aging. 2015; 19(8): 856-60
25. Farooqui T, Farooqui AA. Diet and exercise in cognitive function and neurological diseases. Hoboken: Wiley‐Blackwell; 2015.
26. Maass A, Düzel S, Brigadski T, Goerke M, Becke A, Sobieray U, et al. Relationships of peripheral IGF-1, VEGF and BDNF levels to exercise-related changes in memory, hippocampal perfusion and volumes in older adults. NeuroImage. 2016; 131: 142-54.
27. Duzel E, van Praag H, Sendtner M. Can physical exercise in old age improve memory and hippocampal function? Brain. 2016; 139(3): 662-73.
28. Bhalla S, Mehan S, Khan A, Rehman MU. Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions. Neuroscience & Biobehavioral Reviews. 2022: 104896.
29. Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Molecular neurobiology. 2017; 54: 2269-85.
30. Tosatti JA, Fontes AF, Caramelli P, Gomes KB. Effects of resveratrol supplementation on the cognitive function of patients with Alzheimer's disease: a systematic review of randomized controlled trials. Drugs & Aging. 2022; 39(4): 285-95.